The complete Annex 1 rewrite raises interest in understanding the nuances of cleanroom operations, particularly in terms of occupancy states, classification, and monitoring. We discuss these intricacies here.
This post will explore the technicalities and practical applications of these guidelines, exploring its implications for cleanroom operations and microbial monitoring.
The most recent revision to USP 797 brings forth changes that touch various aspects of pharmaceutical practices. Here, we explore the USP Regulatory Standards Development Process.
This blog post discusses navigating choices in cleanroom viable air monitoring, offering fundamental insights to guide your approach.